A successful case of second autologous haematopoietic stem cell transplantation for post-transplant systemic sclerosis relapse

Clinical and Experimental Rheumatology

Volumn 34, Issue , 2016, Pages 207-207

  Hou, Y ^a   Li, H J ^b   Li, M T ^a   Xu, D ^a   Zhou, D B ^a   Zeng, X F ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b Handan City First Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBON MONOXIDE; CYCLOPHOSPHAMIDE; METHOTREXATE; PREDNISONE; SCL 70 ANTIBODY; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; CD34 SELECTION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LETTER; LEUKAPHERESIS; LUNG FUNCTION TEST; MODIFIED RODNAN SKIN SCORE; PRIORITY JOURNAL; QUALITY OF LIFE; RAYNAUD PHENOMENON; REFLUX ESOPHAGITIS; RELAPSE; REMISSION; SCORING SYSTEM; SKIN DEFECT; SKIN FIBROSIS; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS; WEIGHT GAIN; YOUNG ADULT; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; RECURRENT DISEASE; REOPERATION; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RECURRENCE; REOPERATION; SCLERODERMA, SYSTEMIC; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84994410067     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. van LAAR JM, SULLIVAN K: Stem cell transplantation in systemic sclerosis. Curr Opin Rheumatol 2013; 25: 719-25.
2. BURT RK, SHAH SJ, DILL K et al.: Autologous nonmyeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 2011; 378: 498-506.
3. van LAAR JM, FARGE D, SONT JK et al.: Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014; 311: 2490-8.
4. van LAAR JM, NARAGHI K, TYNDALL A: Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis. Rheumatology (Oxford) 2015; 54: 2126-33.
5. SCHMALZING M, AMANN K, TONY HP: ANCApositive vasculitis as a secondary autoimmune disease after autologous stem cell transplantation for systemic sclerosis: a case report. Clin Exp Rheumatol 2014; 32 (Suppl. 86): S222-4.
6. KHANNA D, GEORGES GE, COURIEL DR: Autologous hematopoietic stem cell therapy in severe systemic sclerosis: ready for clinical practice? JAMA 2014; 311: 2485-7.
7. van de DONK NW, LOKHORST HM, DIMOPOULOS M et al.: Treatment of relapsed and refractory multiple myeloma in the era of novel agents. Cancer Treat Rev 2011; 37: 266-83.